Sabra Health Care REIT (SBRA) CEO awarded 13,358 stock units

Rhea-AI Filing Summary

Sabra Health Care REIT, Inc. reported that Chair, CEO and President Richard K. Matros acquired 13,358 common stock units on February 27, 2026 as a grant or award. The units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carry no purchase price.

These stock units will vest and be paid in shares of common stock on the same schedule as the original awards, on a one-for-one basis. Following this acquisition, Matros directly holds 928,398 common shares, and indirectly holds 1,857,686 shares through the R&A Matros Revocable Trust.

Insider Trade Summary

Net Buyer: 13,358 shares

Net Buy 2 txns

Insider MATROS RICHARD K

Role Chair, CEO and President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,358	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 928,398 shares (Direct); Common Stock — 1,857,686 shares (Indirect, By R&A Matros Revocable Trust)

Footnotes (2)

1. F1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
2. F2. Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/03/2026 - 02:22 PM Learn about SEC filing dates

FAQ

What insider transaction did Sabra Health Care REIT (SBRA) report?

Sabra reported that Chair, CEO and President Richard K. Matros received 13,358 common stock units as a grant. These units were credited as dividend equivalents on existing awards under the 2009 Performance Incentive Plan and require no cash payment.

How many Sabra (SBRA) shares does Richard K. Matros own after this Form 4?

After this Form 4, Richard K. Matros directly holds 928,398 common shares. He also indirectly holds 1,857,686 shares through the R&A Matros Revocable Trust, reflecting both personal and trust-related ownership stakes reported in the filing.

What are dividend equivalent stock units in Sabra’s (SBRA) Form 4?

Dividend equivalent stock units are credits Matros receives instead of cash dividends on prior stock unit awards. At Sabra, these units are calculated using the common stock’s market value on the dividend date and convert into shares on the same vesting terms as the original awards.

Do the new Sabra (SBRA) stock units granted to Matros have a purchase price?

The 13,358 stock units granted to Richard K. Matros have a reported price of $0.00 per unit. They represent compensation credited as dividend equivalents rather than a market purchase, and will settle into common shares when the related awards vest.

How will the new Sabra (SBRA) stock units granted to Matros vest and settle?

The new stock units will vest and become payable on the same schedule as the original stock units they track. Upon settlement, each unit will be paid in one share of Sabra’s common stock, aligning vesting and payment with the underlying incentive awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MATROS RICHARD K

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CA 92782

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chair, CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		13,358(1)	A	$0	928,398(2)	D
Common Stock								1,857,686	I	By R&A Matros Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

2. Consists of stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.